Teva Pharmaceutical Industries Limited (TLV:TEVA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
5,595.00
-95.00 (-1.67%)
Jul 31, 2025, 5:24 PM IDT

Accolade Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
16,62816,54415,84614,92515,87816,659
Upgrade
Revenue Growth (YoY)
2.08%4.41%6.17%-6.00%-4.69%-1.35%
Upgrade
Cost of Revenue
8,3818,4818,2007,9528,2848,933
Upgrade
Gross Profit
8,2478,0637,6466,9737,5947,726
Upgrade
Selling, General & Admin
3,7553,7023,4983,4453,5283,671
Upgrade
Research & Development
977998953838967997
Upgrade
Other Operating Expenses
15-91528203
Upgrade
Operating Expenses
4,7474,6914,4664,3114,5154,671
Upgrade
Operating Income
3,5003,3723,1802,6623,0793,055
Upgrade
Interest Expense
-976-1,002-1,029-930-891-901
Upgrade
Interest & Investment Income
86866810-104
Upgrade
Earnings From Equity Investments
412219138
Upgrade
Currency Exchange Gain (Loss)
-58-17-3016-726
Upgrade
Other Non Operating Income (Expenses)
-21-48-66-62-69-63
Upgrade
EBT Excluding Unusual Items
2,5352,3922,1251,7172,1212,359
Upgrade
Merger & Restructuring Charges
-211-74-111-146-133-120
Upgrade
Impairment of Goodwill
-880-1,280-700-2,045--4,628
Upgrade
Gain (Loss) on Sale of Investments
-----90-
Upgrade
Gain (Loss) on Sale of Assets
171728645819
Upgrade
Asset Writedown
-643-1,275-378-402-584-1,918
Upgrade
Legal Settlements
-824-760-1,038-2,069-698-60
Upgrade
Other Unusual Items
-62-303-548-261-781
Upgrade
Pretax Income
-68-1,283-622-3,142667-4,267
Upgrade
Income Tax Expense
94676-7-643211-168
Upgrade
Earnings From Continuing Operations
-162-1,959-615-2,499456-4,099
Upgrade
Minority Interest in Earnings
53205653-39109
Upgrade
Net Income
-157-1,639-559-2,446417-3,990
Upgrade
Net Income to Common
-157-1,639-559-2,446417-3,990
Upgrade
Shares Outstanding (Basic)
1,1381,1311,1191,1101,1021,095
Upgrade
Shares Outstanding (Diluted)
1,1381,1311,1191,1101,1071,095
Upgrade
Shares Change (YoY)
1.25%1.07%0.81%0.27%1.10%0.37%
Upgrade
EPS (Basic)
-0.14-1.45-0.50-2.200.38-3.64
Upgrade
EPS (Diluted)
-0.14-1.45-0.50-2.200.38-3.64
Upgrade
Free Cash Flow
8907498421,042236638
Upgrade
Free Cash Flow Per Share
0.780.660.750.940.210.58
Upgrade
Gross Margin
49.60%48.74%48.25%46.72%47.83%46.38%
Upgrade
Operating Margin
21.05%20.38%20.07%17.84%19.39%18.34%
Upgrade
Profit Margin
-0.94%-9.91%-3.53%-16.39%2.63%-23.95%
Upgrade
Free Cash Flow Margin
5.35%4.53%5.31%6.98%1.49%3.83%
Upgrade
EBITDA
4,5224,4314,3333,9704,4094,612
Upgrade
EBITDA Margin
27.20%26.78%27.34%26.60%27.77%27.68%
Upgrade
D&A For EBITDA
1,0221,0591,1531,3081,3301,557
Upgrade
EBIT
3,5003,3723,1802,6623,0793,055
Upgrade
EBIT Margin
21.05%20.38%20.07%17.84%19.39%18.34%
Upgrade
Effective Tax Rate
----31.63%-
Upgrade
Advertising Expenses
----246225
Upgrade
Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.